NASDAQ NMS - GLOBAL MARKET · NPCE
-3.25% · -$0.4600 · Vol 208.5K
Live · updated 15:59:48 ET
Neuropace Inc

Neuropace Inc

Health Care
$13.68
Card
Relationship Map

Veridion Score

BETALOW CONF · 5/6 factorsMethodology
NPCE
Neuropace Inc
Wed Aug 5 · live session · daily score · 3h old
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

48/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: LOW · 5/6 factors with data · Wed Aug 5 · live session · daily score · 3h old
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is NPCE moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading NPCE catalysts
About Neuropace Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2021
Employees
220
Country
US

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$14.14
Day high
$14.22
Day low
$13.32
Previous close
$14.14
52W high
$19.29
-29.08% from high
52W low
$8.25
49% of range
Market cap
$482.1M
EPS
$-0.7800
Beta
1.24
Shares out
34.1M
Volume
208.5K
0.95× rel vol
Avg volume
220.5K
VWAP
$13.61
Price history computed in-house
1W
+0.29%
1M
-21.06%
3M
-29.08%
1Y
+57.24%
YTD
-11.40%
SMA 50 $15.83 · below
SMA 200 $15.12 · below
52W position 49%

NPCE overview

Loading financial statements
Loading NPCE Form 4 filings
Public disclosures

Congress activity in NPCE

No receipt-qualified Congressional disclosure is present for NPCE in the cached public ledger.

Federal contracts

NPCE contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for NPCE in this window.
Lobbying spend

NPCE lobbying filings, year to date.

Registered lobbying filings matched to Neuropace Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for NPCE in this window.
Loading news for NPCE
Analyst ratings
Sovereign unlock shows live analyst consensus for NPCE.
Options
Sovereign unlock shows live options positioning for NPCE.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.